Intersectional Stigma Experiences, Pre-exposure Prophylaxis (PrEP), and Other Service Use Among People Who Inject Drugs
Funded by: National Institute on Drug Abuse
Project dates: May 2021 - April 2026
Principal Investigator: Walters, SuzanProject dates: May 2021 - April 2026
PROJECT DESCRIPTION
People who inject drugs (PWID) are at risk for HIV, and pre-exposure prophylaxis (PrEP) could be an effective means of HIV prevention. PrEP uptake is low among PWID because of numerous barriers, one of which is stigma due to multiple intersecting characteristics such as drug use, race/ ethnicity, sexual identity, gender, poverty, HIV, and PrEP (i.e., intersectional stigma). This study aims to determine the relationship between intersectional stigma and PrEP willingness and uptake, as well as associations with other service use (i.e., healthcare, drug treatment, pharmacies, or syringe exchange programs) over time.
Abstract on NIH RePORTERRelated Publications
Walters SM, Kerr J, Cano M, Earnshaw V, Link B (2023). Intersectional stigma as a fundamental cause of health disparities: A case study of how drug use stigma intersecting with racism and xenophobia creates health inequities for Black and Hispanic persons who use drugs over time
Stigma and Health, 8 (3), 325-343. doi: 10.1037/sah0000426. PMCID: PMC10516303.